American Society for Clinical Investigation honors physician-scientists (Links to an external site)
Tag: diabetes
Herrick publishes study on social determinants in health documentation
In February, Cynthia Herrick, MD and colleagues had their research titled “The adoption of social determinants of health documentation in clinical settings,” published in “Health Services Research.” The study was focused on understanding “the frequency of social determinants of health (SDOH) diagnosis codes (Z-codes) within the electronic health record for patients with prediabetes and diabetes […]
McKee publishes article on continuous glucose monitoring
On December 19, Alexis M. McKee, MD, CDCES, published an article on “EndocrineWeb,” titled “Is Continuous Glucose Monitoring for You?” The first continuous glucose monitor (CGM) came to existence in the early 2000s. The prior method of blood sugar testing at the time was fingerstick glucose reading. “By 2016, the accuracy of CGM sensors was so […]
Study reveals obesity-related trigger that can lead to diabetes (Links to an external site)
McGill publishes updated clinical guideline on diabetes mellitus care
In October, Janet B. McGill, MD, MA, FACP, and collaborators had their work published in “Endocrine Practice,” titled “American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update.” Their objective was “to provide updated and new evidence-based recommendations for the comprehensive care of persons with diabetes mellitus to clinicians, […]
McKee publishes article on automated insulin delivery
On November 18, Alexis M. McKee, MD, CDCES had her article titled “What is Automated Insulin Delivery,” published on “EndocrineWeb.” Automated insulin delivery (AID) delivers insulin through a pump that communicates with a continuous glucose monitor (CGM). Also known as a hybrid closed hoop system or an artificial pancreas device system. In the article, McKee […]
McKee publishes article on Insulin Glargine
On September 13, Alexis M. McKee, MD, CDCES had an article published on “Endocrine Web,” titled “What Is Insulin Glargine and What Are Its Side Effects?” Insulin glargine is a long-acting insulin, sometimes referred to as basal. When glargine was discovered, it was a game-changer in diabetes management because it allowed those with diabetes to stop using […]
Diabetes Day Symposium 2022
On November 10, our annual Diabetes Day Symposium took place at the Eric P. Newman Education Center. The event hosted guest speaker Debbie Thurmond, PhD, of City of Hope Beckman Research Institute, presenting “Reversing Type 2 Diabetes: Getting the Band Back Together.” Also taking place during the symposium, fifty-eight poster presenters showcased their work to […]
Semenkovich publishes research on mechanisms to improve targeted atherosclerosis therapy
On June 15, Clay F. Semenkovich, MD and collaborators had their research titled “Altered Peroxisome Proliferator-Activated Receptor Alpha Signaling in Variably Diseased Peripheral Arterial Segments,” published in “Frontiers in Cardiovascular Medicine.” “Peripheral atherosclerosis that accumulates in the extracranial carotid and lower extremity arteries can lead to significant morbidity and mortality. However, atherosclerotic disease progression is […]
McGill, Salam and McKee get first patient for clinical trial testing Biosense device for those with Type 1 Diabetes
Washington University School of Medicine recently received a two-year grant of $360,000 from JDRF to fund research testing the efficacy of the Biosense handheld breath ketone monitor in persons with type 1 diabetes during care with insulin and with the addition of a sodium glucose transporter inhibitor drug. Biosense is a non-invasive option to capillary […]